Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 24, 2018Annals of the Rheumatic DiseasesOpen Access

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMichèlle RosenzwajgMACOM (United States)RLRoberta LorenzonInserm
P. Cacoub
P. CacoubInstitute of Ismaili Studies

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rosenzwajg et al. (2018) studied this question.

synapsesocial.com/papers/6aa0343c774e58bea3d4f1ebhttps://doi.org/10.1136/annrheumdis-2018-214229
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity2014 · 204 citations
  2. 2Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses2018 · 74 citations
  3. 3Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells2016 · 718 citations